Zafirlukast — Membership Pricing
Zafirlukast is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.
Zafirlukast Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Membership pricing may be available |
| Typical Retail | $68.00 |
Membership pricing may be available; confirm the price with the dispensing pharmacy.
About Zafirlukast
Zafirlukast is a prescription medication. Ask your doctor if Zafirlukast is right for you.
How to Check Zafirlukast Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Zafirlukast at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Respiratory
About Zafirlukast
Zafirlukast is a medication commonly prescribed for the long-term management of asthma symptoms. It plays a crucial role in helping individuals breathe easier and reduce the frequency of asthma attacks. Understanding how it works and its potential costs is essential for effective treatment. With TheDrugClub, you can also explore significant savings on your zafirlukast prescription, making your healthcare more affordable.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Zafirlukast is approved for (FDA label)
Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.
Source: Read the full FDA label on DailyMed. Label effective date: March 16, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Zafirlukast (FDA label)
Adults and Children 12 years of age and older The safety database for zafirlukast consists of more than 4000 healthy volunteers and patients who received zafirlukast, of which 1723 were asthmatics enrolled in trials of 13 weeks duration or longer. A total of 671 patients received zafirlukast for 1 year or longer. The majority of the patients were 18 years of age or older; however, 222 patients between the age of 12 and 18 years received zafirlukast. A comparison of adverse events reported by ≥1% of zafirlukast-treated patients, and at rates numerically greater than in placebo-treated patients, is shown for all trials in the table below.
Source: FDA prescribing information (DailyMed). Set ID: baba507f-6557-4551-815c-9ab6606e4ee1. SPL document ID: e219b453-57d0-4835-9ac3-4bd73f3b0391. Label effective date: March 16, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Zafirlukast (FDA label)
Zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. Zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.
Source: FDA prescribing information (DailyMed). Set ID: baba507f-6557-4551-815c-9ab6606e4ee1. SPL document ID: e219b453-57d0-4835-9ac3-4bd73f3b0391. Label effective date: March 16, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.